Encompass Health Corp
Close on Oct 19, 2026
- Market cap
- $12.17B
- P/E (TTM)
- 19.8
- Dividend yield
- 0.59%
Earnings
Next report expected Oct 28, 2026, during market hours (estimated from past report dates)
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2026 Ended Jun 30, 2026 | Aug 5, 2026 | During market hours | – | – | – |
| Q1 FY2026 Ended Mar 31, 2026 | Apr 30, 2026 | During market hours | $1.59B | $1.77 | $1.60 |
| Q4 FY2025 Ended Dec 31, 2025 | Feb 5, 2026 | During market hours | $1.54B | $1.42 | $1.46 |
| Q3 FY2025 Ended Sep 30, 2025 | Oct 29, 2025 | During market hours | $1.48B | $1.24 | $1.23 |
| Q2 FY2025 Ended Jun 30, 2025 | Aug 4, 2025 | During market hours | $1.46B | $1.39 | $1.40 |
| Q1 FY2025 Ended Mar 31, 2025 | Apr 24, 2025 | During market hours | $1.46B | $1.48 | $1.37 |
| Q4 FY2024 Ended Dec 31, 2024 | Feb 6, 2025 | During market hours | $1.41B | $1.18 | $1.17 |
| Q3 FY2024 Ended Sep 30, 2024 | Oct 28, 2024 | During market hours | $1.35B | $1.07 | $1.03 |
| Q2 FY2024 Ended Jun 30, 2024 | Aug 5, 2024 | During market hours | – | – | – |
| Q1 FY2024 Ended Mar 31, 2024 | Apr 24, 2024 | During market hours | – | – | – |
| Q4 FY2023 Ended Dec 31, 2023 | Feb 7, 2024 | During market hours | – | – | – |
Company guidance
Outlook given with results on Aug 5, 2026, compared with the previous outlook
| Measure | Period | Guidance | vs. prior |
|---|---|---|---|
| Interest expense and amortization of debt discounts and feesGAAP | 2026 | $130.00M | Raised |
| Amortization of debt-related itemsGAAP | 2026 | $10.00M | Lowered |
Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.
Press releases
Announcements Encompass Health filed with the SEC
Encompass Health reports results for second quarter 2026
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
2026 Second Quarter Earnings Call August 6, 2026 Supplemental information
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Encompass Health announces pricing of $500 million of senior notes due 2034 in a private offering
Material agreement · Other events · EX-99.1 to Form 8-K
Encompass Health reports results for first quarter 2026
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
2026 First Quarter Earnings Call May 1, 2026 Supplemental information
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Encompass Health reports results for fourth quarter 2025
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
2025 Fourth Quarter Earnings Call February 6, 2026 Supplemental information
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Encompass Health reports results for third quarter 2025
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
2025 Third Quarter Earnings Call October 30, 2025 Supplemental information
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Encompass Health reports results for second quarter 2025
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
2025 Second Quarter Earnings Call August 5, 2025 Supplemental information
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Investor Reference Book Published: June 25, 2025
Regulation FD disclosure · EX-99.1 to Form 8-K
Encompass Health reports results for first quarter 2025
Results of operations · Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
2025 First Quarter Earnings Call April 25, 2025 Supplemental information
Results of operations · Executive or director change · Regulation FD disclosure · EX-99.2 to Form 8-K
Encompass Health announces promotion of Patrick Tuer to newly established COO position
Results of operations · Executive or director change · Regulation FD disclosure · EX-99.3 to Form 8-K
Encompass Health reports results for fourth quarter 2024
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
2024 Fourth Quarter Earnings Call February 7, 2025 Supplemental information
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Encompass Health reports results for third quarter 2024
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
2024 Third Quarter Earnings Call October 29, 2024 Supplemental information
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Encompass Health reports results for second quarter 2024
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
2024 Second Quarter Earnings Call August 6, 2024 Supplemental information
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Investor Reference Book Published: June 21, 2024
Regulation FD disclosure · EX-99.1 to Form 8-K
Encompass Health reports results for first quarter 2024
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
2024 First Quarter Earnings Call April 25, 2024 Supplemental information
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Encompass Health reports results for fourth quarter 2023
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Earnings Call April 28, 2022 Supplemental information 2022 First Quarter3 ourth Quarter a l February 8, 2024 Supplemental information
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Encompass Health reports results for third quarter 2023
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Earnings Call April 28, 2022 Supplemental information 2022 First Quarter3 Third Quarter a l October 27, 2023 Supplemental information
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
2023 Investor Day Encompass Health
Regulation FD disclosure · EX-99.1 to Form 8-K
Encompass Health reports results for second quarter 2023
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Earnings Call April 28, 2022 Supplemental information 2022 First Quarter3 Second Quarter a l August 2, 2023 Supplemental information
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Investor Reference Book Published: May 31, 2023
Regulation FD disclosure · EX-99.1 to Form 8-K
Encompass Health reports results for first quarter 2023
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Earnings Call April 28, 2022 Supplemental information 2022 First Quarter3 irst Quarter a l April 28, 2023 Supplemental information
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Encompass Health reports results for fourth quarter 2022
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Earnings Call April 28, 2022 Supplemental information 2022 First Quarter ourth Quarter a l February 8, 2023 Supplemental information
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Encompass Health reports results for third quarter 2022
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Earnings Call April 28, 2022 Supplemental information 2022 First Quarter Third Quarter a l October 27, 2022 Supplemental information
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K
Encompass Health reports results for second quarter 2022
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Earnings Call April 28, 2022 Supplemental information 2022 First Quarter Second Quarter a l August 2, 2022 Supplemental information
Results of operations · Regulation FD disclosure · EX-99.2 to Form 8-K